PATENT CLAIM ANALYSIS

Application Number: 15881392
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-10
Patent Classification: ["424", "135100"]

Abstract:
The invention relates to antibodies, antibody fragments and binding agents that specifically recognize oligomeric tau but do not bind to monomeric tau, fibrillar tau or non-disease associated forms of tau.

Claim (Index 33):
A method of detecting the presence of tau in a physiological sample, the method comprising\n contacting a physiological sample with the binding molecule of  claim 21 ; and determining the binding of the binding molecule with said physiological sample wherein binding of the binding molecule to said physiological sample is indicative of the presence of tau oligomers in said physiological sample, wherein said presence of said tau oligomers is indicative of early stage Alzheimer's disease (AD), frontotemporal dementia, other tauopathies, or neurodegeneration following traumatic brain injury.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 86.0
- Lexical Diversity: 1.17857
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15479110', '15424444', '14434742', '15114356', '13821172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7973251841667182
- 35 USC 102 Novelty (BERT): 0.7159971967549287
- Combined Prediction Score: 0.7891923854255392
- Mean Citation Score: 641.993554
- Max Citation Score: 799.7855
- Similarity Product: 765.9089158869386

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test